Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
HALO · against 131 other Healthcare companies of similar size
Ranked #72 of 132 · scores higher than 45% of peers
Bars: peers in each 10-point band of the valuation score17 peers with a valuation score of 50–59, including HALO · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | HALO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 130 reported | 2.7% | 2.8% | 47% | 30% | |
| EBITDA yieldHigher is better · 133 reported | 6.4% | 4.8% | 60% | 50% | |
| Free cash flow yieldHigher is better · 87 reported | 3.6% | 2.9% | 58% | 20% | |
| Book yieldHigher is better · 130 reported | 1.0% | 21.2% | 4% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 89.5B HKD (≈$11.5B) | 98 | 67 | |
| 2 | 10.4B USD | 96 | 64 | |
| 3 | 80.2B CNY (≈$11.2B) | 95 | 76 | |
| 3 | 21.5B USD | 95 | 60 | |
| 5 | 11.6B USD | 94 | 58 | |
| 68 | 9.3B USD | 55 | 64 | |
| 70 | 166.5B SEK (≈$16.6B) | 54 | 49 | |
| 70 | 16.1B CHF (≈$18.5B) | 54 | 54 | |
| 72 | 13.8B USD | 53 | 54 | |
| 72 | 14.6B USD | 53 | 59 | |
| 74 | 10.0B USD | 52 | 43 | |
| 74 | 21.7B USD | 52 | 32 | |
| 76 | 18.5B USD | 51 | 62 | |
| 76 | 11.9B USD | 51 | 53 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score